000			02206 a2200685 4500
005			20250517094426.0
264		0	_c20180116
008			201801s 0 0 eng d
022			_a1476-5403
024	7		_a10.1038/cdd.2016.46 _2doi
040			_aNLM _beng _cNLM
100	1		_aNewton, K
245	0	0	_aRIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. _h[electronic resource]
260			_bCell death and differentiation _c09 2016
300			_a1565-76 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCeruletide _xtoxicity
650	0	4	_aColitis _xchemically induced
650	0	4	_aDextran Sulfate _xtoxicity
650	0	4	_aDisease Models, Animal
650	0	4	_aFemale
650	0	4	_aInflammation _xmetabolism
650	0	4	_aLipopolysaccharides _xtoxicity
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aPancreatitis _xchemically induced
650	0	4	_aProtein Kinases _xdeficiency
650	0	4	_aReceptor-Interacting Protein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aReperfusion Injury _xmetabolism
650	0	4	_aSepsis _xetiology
650	0	4	_aSystemic Inflammatory Response Syndrome _xetiology
650	0	4	_aTumor Necrosis Factor alpha-Induced Protein 3 _xdeficiency
700	1		_aDugger, D L
700	1		_aMaltzman, A
700	1		_aGreve, J M
700	1		_aHedehus, M
700	1		_aMartin-McNulty, B
700	1		_aCarano, R A D
700	1		_aCao, T C
700	1		_avan Bruggen, N
700	1		_aBernstein, L
700	1		_aLee, W P
700	1		_aWu, X
700	1		_aDeVoss, J
700	1		_aZhang, J
700	1		_aJeet, S
700	1		_aPeng, I
700	1		_aMcKenzie, B S
700	1		_aRoose-Girma, M
700	1		_aCaplazi, P
700	1		_aDiehl, L
700	1		_aWebster, J D
700	1		_aVucic, D
773	0		_tCell death and differentiation _gvol. 23 _gno. 9 _gp. 1565-76
856	4	0	_uhttps://doi.org/10.1038/cdd.2016.46 _zAvailable from publisher's website
999			_c26017750 _d26017750